{"id":1114,"date":"2023-06-06T15:10:36","date_gmt":"2023-06-06T13:10:36","guid":{"rendered":"https:\/\/www.isrec.ch\/archives\/"},"modified":"2024-01-26T09:41:50","modified_gmt":"2024-01-26T08:41:50","slug":"archive","status":"publish","type":"page","link":"https:\/\/www.isrec.ch\/en\/the-research\/archive\/","title":{"rendered":"Archive"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Summary of the supported projects<\/h2>\n\n\n\n<p>List of the funds and grants allocated by the ISREC Foundation since 2008 for the support of translational cancer research projects or for the encouragement of the scientific and academic future in cancer research:<\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n    <div class=\"search-article-by-category \">\n        <div class=\"search-articles-list accordions\">\n            \n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/mycosis-fungoides-prof-emmanuella-guenova-chuv\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Mycosis fungoides<\/strong> &#8211; Prof. Emmanuella Guenova (CHUV)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/unravelling-the-rules-for-t-cell-recognition-of-cancer-epitopes-prof-david-gfeller\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Mechanisms of recognition of cancer cells by the immune system<\/strong>\u00a0&#8211; Prof. David Gfeller (UNIL)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/mirror-therapy-for-phantom-breast-syndrome\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>New treatment for phantom breast syndrome<\/strong> &#8211; Dr. Filipe Martins (EPFL)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/combination-tki-and-next-generation-car-t-cells-for-improved-treatment-of-sarcoma\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Immunotherapy for Sarcoma Treatment<\/strong> &#8211; Dr. Antonia Digklia (CHUV) and Dr. Melita Irving (CHUV)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/network-based-drug-response-and-repurposing-at-single-cell-resolution-nereus\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Bladder cancer<\/strong> &#8211; Prof. Marianna Kruithof-de Julio (UNIBE) and Dr. Bernhard Kiss (INSEL)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/the-microbiota-eosinophil-axis-as-a-critical-regulator-of-disease-course-metastasis-and-therapy-response-in-patients-with-colorectal-cancer\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Colorectal cancer<\/strong> &#8211; Prof. Dr. Michael Scharl (USZ) and Prof. Dr. Isabelle Arnold Wall\u00e9n (UZH)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/survey-on-cancer-patient-reported-healthcare-experiences-in-switzerland\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Analysis of Oncology Patient Data<\/strong> &#8211; Chantal Arditi (Unisant\u00e9)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/customizing-treatment-in-cancer-patients-uncovering-cancer-vulnerabilities\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Identification of Personalized Therapeutic Strategies<\/strong> &#8211; Prof. Dr med. Chantal Pauli (USZ)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/developing-off-the-shelf-allogeneic-chimeric-antigen-receptor-t-cells-for-childhood-leukemia\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Developing off-the-shelf allogeneic chimeric antigen receptor T cells for childhood leukemia<\/strong> &#8211; Prof. Caroline Arber (CHUV)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/targeting-novel-molecular-networks-underlying-bladder-cancer-recurrence-and-progression\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Bladder Cancer<\/strong> &#8211; Prof. Camilla Jandus (UNIGE) and Prof. Gr\u00e9gory Verdeil (UNIL)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/understanding-how-clonal-hematopoiesis-feeds-lymphoma\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>The lymphoma microenvironment<\/strong> &#8211; Prof. Davide Rossi (USI\/IOR)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/advanced-in-vitro-models-of-prostate-cancer-metastases-unravelling-and-overcoming-arsi-resistance\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Prostate Cancer<\/strong> &#8211; Prof. Mark Rubin (UNIBE)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/modeling-and-investigating-the-tumor-microenvironment-of-non-small-cell-lung-cancer-brain-metastasis\/\">\n            <div class=\"accordion-header-bis\">\n                <h3>Beno\u00eet Duc, MD-PhD in the laboratory of Prof. Johanna Joyce (UNIL\/LUDWIG) &#8211; (Lung cancer and brain metastases)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/patient-and-healthcare-provider-experience-in-adoptive-cell-therapies-an-experience-based-co-design-study\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Analysis of Data from Patients Undergoing Immunotherapy<\/strong> &#8211; Prof. Dr. rer. med. Manuela Eicher (IUFRS)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/exploring-the-role-of-neutrophils-in-brain-metastasis\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Brain Tumors<\/strong> &#8211; Prof. Johanna Joyce (LUDWIG\/UNIL)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/immune-modulatory-radiotherapy-to-enhance-the-effects-of-neo-adjuvant-pd-l1-blockade-after-neo-adjuvant-chemotherapy-in-patients-with-resectable-stage-iii-n2-non-small-cell-lung-cancer-nsclc\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Immune-modulatory radiotherapy to enhance the effects of neo-adjuvant PD-L1 blockade after neo-adjuvant chemotherapy in patients with resectable stage III (N2) non-small cell lung cancer (NSCLC)<\/strong> &#8211; Dr. Sacha Rothschild (University Hospital Basel)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/mechanisms-and-therapeutic-targeting-of-the-neuronal-nmdar-signaling-pathway-promoting-breast-cancer-pathogenesis\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Simge Y\u00fccel, PhD, Breast Cancer<\/strong> &#8211; Prof. Douglas Hanahan and Prof. Michele De Palma (EPFL\/SV\/ISREC)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/translational-study-toward-the-development-of-a-test-for-the-early-detection-of-primary-breast-cancer-and-breast-cancer-relapse\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Breast Cancer Screening<\/strong> &#8211; Prof. Curzio R\u00fcegg (UNIFR)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/clinical-translation-of-flash-therapy\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Clinical translation of FLASH therapy<\/strong> &#8211; Prof. Jean Bourhis (CHUV)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/development-of-a-novel-b-cell-based-vaccine-for-metastatic-solid-cancers\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Therapeutic Cancer Vaccines<\/strong> &#8211; Prof. Lana Kandalaft (UNIL\/CHUV)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/biochemical-identification-and-characterization-of-pd1-signaling-components\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>Biochemical identification and characterization of PD1 signaling components<\/strong> &#8211; Professor Margot Thome Miazza (UNIL, Biochemistry Department)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n<div class=\"accordion-item\">\n    <div class=\"accordion-item\">\n        <a href=\"https:\/\/www.isrec.ch\/en\/research\/the-role-of-androgen-receptor-signaling-in-estrogen-receptor-positive-breast-cancer\/\">\n            <div class=\"accordion-header-bis\">\n                <h3><strong>The Role of Androgen Receptor Signaling in Estrogen Receptor-Positive Breast Cancer<\/strong> &#8211; Prof. Cathrin Brisken (EPFL\/SV\/ISREC)<\/h3>\n            <\/div>\n        <\/a>\n    <\/div>\n<\/div>\n                \n                    <\/div>\n    <\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 3, 2023 \u2013 August 25,&nbsp;2023<\/h3>\n\n\n\n<p>Grants for 4&nbsp;students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 2 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">December 2020 &#8211; August 2023<\/h3>\n\n\n\n<p>Allocated fund in pediatric cancer research<\/p>\n\n\n\n<p><em><strong>Methylation Profiling in Rhabdomyosarcoma<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund in pediatric cancer research\u201d was granted to Dr. Eva Brack (Pediatric Oncology Department, Inselspital, Bern) in December 2020.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">October 2020 &#8211; April 2022<\/h2>\n\n\n\n<p>Allocated fund<\/p>\n\n\n\n<p><em><strong>BET &#8211; Bio-Engineering and Technology<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d was granted in October 2020 for the establishment of the BET lab at the heart of the AGORA \u2013 P\u00f4le de recherche sur le cancer.\u00a0<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-default\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">September 2019 &#8211; August 2023<\/h3>\n\n\n\n<p>ISREC grant<\/p>\n\n\n\n<p><em><strong>The Role of Androgen Receptor Signaling in Estrogen Receptor-Positive Breast Cancer<\/strong><\/em><\/p>\n\n\n\n<p>This \u00ab ISREC grant \u00bb was awarded to Andrea Agnoletto in September 2019 . Andrea Agnoletto is working in the lab of Prof. Cathrin Brisken, EPFL\/SV\/ISREC.&nbsp;<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">August 2019 &#8211; July 2023<\/h3>\n\n\n\n<p>ISREC grant<\/p>\n\n\n\n<p><em><strong>Biochemical identification and characterization of PD1 signaling components<\/strong><\/em><\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Silvia Podavini in August 2019. Silvia Podavini is working in the group of Professor Margot Thome Miazza (UNIL, Biochemistry Department).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">April 2019 &#8211; March 2023<\/h3>\n\n\n\n<p>ISREC grant &#8220;Cancer and Immunology&#8221;<\/p>\n\n\n\n<p><em><strong>Study of the Role of NFAT5 in Tumor-Specific CD8 T Cells<\/strong><\/em><\/p>\n\n\n\n<p>This &#8220;ISREC grant&#8221; was awarded to Daniela Cropp in April 2019 for four years. Daniela Cropp is performing her research in the lab of Dr. Gr\u00e9gory Verdeil (UNIL, Department of Fundamental Oncology).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">October 2020 &#8211; September 2022<\/h3>\n\n\n\n<p>Allocated fund in clinical research<\/p>\n\n\n\n<p><em><strong><em><strong>Targeting tumor-infiltrating myeloid cells for prostate cancer therapy<\/strong><\/em><\/strong><\/em><\/p>\n\n\n\n<p>This allocated fund in clinical research was granted in October 2020 to Prof. Andrea Alimonti and his research team (Institute of Oncology Research) for two years.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><strong>July 4 \u2013 August 26,&nbsp;2022<\/strong><\/strong><\/h3>\n\n\n\n<p>Grants for 4&nbsp;students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 2 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">November 2018 &#8211; April 2022<\/h3>\n\n\n\n<p>Allocated fund for nursing research<\/p>\n\n\n\n<p><em><strong>A Model of Care Based on Electronic Patient-Reported Outcomes for the Early Detection and Management of Immune-Related Adverse Events in Patients Under Immunotherapy: A Multicentric Phase II Randomized Controlled Trial (IePRO).<\/strong><\/em><\/p>\n\n\n\n<p>Prof. Dr. rer. Med. Manuela Eicher and Prof. Dr. med. Olivier Michielin have been awarded this \u201callocated fund for nursing research\u201d, derived from a private donation, starting in November 2018.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">June 2013 &#8211; February 2022<\/h3>\n\n\n\n<p>ISREC grant &#8220;Oncology &#8220;<\/p>\n\n\n\n<p><em><strong>Molecular Cancer Immunotherapy and Immune Engineering<\/strong><\/em><\/p>\n\n\n\n<p>This immune engineering chair was allocated to the research group of Prof. Ping-Chih Ho (UNIL\/LUDWIG) in June 2013.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">October 2020 &#8211; September 2021<\/h3>\n\n\n\n<p>Allocated fund for nursing research<\/p>\n\n\n\n<p><em><strong>Distress Management<\/strong><\/em><\/p>\n\n\n\n<p>Prof. Dr. rer. Med. Manuela Eicher has been awarded this \u201callocated fund for nursing research\u201d, for 1 year, starting in October 2020 (Institute of Higher Education and Research in Healthcare).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>July 5&nbsp;\u2013 August 27,&nbsp;2021<\/strong><\/h3>\n\n\n\n<p>Grants for 2&nbsp;students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 3 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2020 &#8211; June 2021<\/h3>\n\n\n\n<p>Allocated fund for nursing research<\/p>\n\n\n\n<p><em><strong>Development of a framework and toolkit for patient and public involvement in cancer research focusing on patient reported outcome \/ experience measures<\/strong><\/em><\/p>\n\n\n\n<p>Prof. Dr. rer. Med. Manuela Eicher has been awarded this \u201callocated fund for nursing research\u201d, for 1 year, starting in July 2020 (Institute of Higher Education and Research in Healthcare).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2019&nbsp;&#8211; December 2020<\/h3>\n\n\n\n<p>Allocated fund in Genetics and Genomics<\/p>\n\n\n\n<p><em><strong>Deciphering Tumorigenesis Driven by Replication-Associated DNA Damage<\/strong><\/em><\/p>\n\n\n\n<p>This \u00ab Allocated Fund in Genetics and Genomics \u00bb was granted in January 2019 to Prof. Massimo Lopes (University of Zurich) and to Prof. Achim Weber (University Hospital Zurich) for 2 years.&nbsp;<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2019&nbsp;&#8211; December 2020<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><em><strong>lnvestigating the Functional Role of Cellular Phenotypes in Melanoma Targeted Therapy<\/strong><\/em><\/p>\n\n\n\n<p>This \u201cAllocated Fund in oncogenic signaling\u201d was granted in January 2019 to Prof. Reinhard Dummer (Department of Dermatology, University Hospital Zurich) and Prof. Lukas Sommer (Institute of Anatomy, University of Zurich) for 2 years.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">November 2019&nbsp;&#8211; October 2020<\/h3>\n\n\n\n<p>ISREC grant &#8220;Translational Oncology &#8220;<\/p>\n\n\n\n<p><em><strong>Identification of molecular mechanisms underlying CIC-DUX4 tumor pathogenesis and aggressiveness<\/strong><\/em><\/p>\n\n\n\n<p>This &#8220;MD-PhD scholarship&#8221; was awarded to Arnaud Bakaric in November 2019 for a period of 1 year in support of his thesis in basic medical sciences, with a view to becoming a clinical scientist. Arnaud Bakaric is working in the laboratory of Prof. Nicolo Riggi, Institute of Pathology UNIL-CHUV.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">November 2014&nbsp;&#8211; October 2020<\/h3>\n\n\n\n<p>ISREC chair &#8220;Translational Oncology &#8220;<\/p>\n\n\n\n<p><em><strong>Decoding the genetics of lymphoma for the development of new therapies<\/strong><\/em><\/p>\n\n\n\n<p>This chair was allocated in November 2014 for a period of 6 years. It was awarded to the research group of Prof. Elisa Oricchio (EPFL\/SV\/ISREC).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2016 &#8211; December 2019<\/h3>\n\n\n\n<p>ISREC grant &#8220;Cancer and Immunology&#8221;<\/p>\n\n\n\n<p><em><strong>Tumor-specific cytolytic CD4 T cells in protective immunity against human cancer<\/strong><\/em><\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Am\u00e9lie Cachot in Januar 2016 for four years.<br>Am\u00e9lie Cachot is working in the group of Prof. Pedro Romero, LICR@UNIL.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>July 8&nbsp;\u2013 August 29,&nbsp;2019<\/strong><\/h3>\n\n\n\n<p>Grants for 6&nbsp;students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 1&nbsp;student&nbsp;of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2016 &#8211; July 2019<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><em><strong>Immune engineering: Platform for the development of T-cell-based immune therapies<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from the Biltema Foundation was granted in July 2016 for 3 years.&nbsp;<br>Research laboratories of Prof. George Coukos (CHUV\/UNIL\/LICR).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2016 &#8211; July 2019<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><em><strong>Immune engineering<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from the Biltema Foundation was granted in July 2016 for 3 years.&nbsp;<br>Research laboratories of Professors Matthias Lutolf, Philippe Renaud, Hatice Altug and Harm-Anton Klok (EPFL\/IBI) in collaboration with the research teams at the LICR Lausanne Branch.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2016 &#8211; July 2019<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><em><strong>Breast cancer<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from the Biltema Foundation was granted in July 2016 for 3 years.&nbsp;<br>Research laboratories of Prof. Ake Borg (Lund University, Sweden) and Prof. Catherine Brisken (EPFL\/SV\/ISREC) on the one hand (ER+ breast cancer), and of Prof. Douglas Hanahan (EPFL\/SV\/ISREC) and Prof. Kristian Pietras (Lund University, Sweden) on the other hand (triple negative breast cancer).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2016 &#8211; July 2019<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><em><strong>Development of antibody therapies for solid tumors and acute myeloid leukemia<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from the Biltema Foundation was granted in July 2016 for 3 years.&nbsp;<br>Research laboratories of Prof. Carl Borrebaeck and Prof. Thoas Fioretos (Lund University, Sweden), in collaboration with the research teams at the LICR Lausanne Branch.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2016 &#8211; July 2019<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><em><strong>Personalized immunotherapy<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from the Biltema Foundation was granted in July 2016 for 3 years.&nbsp;<br>Research laboratory of Prof. George Coukos (CHUV\/UNIL\/LICR).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2016 &#8211; July 2019<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><em><strong>Flash Radiotherapy&nbsp;<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from the Biltema Foundation was granted in July 2016 for 3 years.&nbsp;<br>Research laboratory of Prof. Jean Bourhis (CHUV\/UNIL).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 2015&nbsp;&#8211; July&nbsp;2019<\/h3>\n\n\n\n<p>Allocated fund &#8220;Scientific and academic training&#8221;<\/p>\n\n\n\n<p><em><strong>Molecular mechanisms regulating TCR affinity-improved T cells against cancer.<\/strong><\/em><\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Efe Erdes in July 2015 for 4 years.&nbsp;Efe Erdes is working in the group of Prof. Nathalie Rufer (Department of Oncology, UNIL\/CHUV).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2018 &#8211; December 2018<\/h3>\n\n\n\n<p><br>Allocated fund &#8220;Translational research&#8221;<\/p>\n\n\n\n<p><strong><em>A new dialogue between neutrophils and tumor cell Snail orchestrates lung adenocarcinoma progression<\/em><\/strong><\/p>\n\n\n\n<p>This \u00aballocated fund\u00bb was granted in January 2018 for 1 year. It was awarded to Prof. Etienne Meylan (EPFL\/SV\/ISREC).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">September 2014 &#8211; September 2018<\/h3>\n\n\n\n<p>Allocated fund &#8220;Fundamental research&#8221;<\/p>\n\n\n\n<p><strong><em>Analysis of genomic instability in normal and cancer cells studied ex vivo<\/em><\/strong><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from the Fondation de Bienfaisance Pictet was granted in September 2014 for 4 years.&nbsp;It was awarded to the research laboratories of Prof. Joerg Huelsken (EPFL\/SV\/ISREC).&nbsp;Collaboration between the EPFL and the Geneva University Hospital.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 4 \u2013 August 29, 2018<\/h3>\n\n\n\n<p>Grants for 5 students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 5 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">February 2016 &#8211; February 2018<\/h3>\n\n\n\n<p>Allocated fund &#8220;Immunotherapy&#8221;<\/p>\n\n\n\n<p><strong><em>Ovarian Cancer Research &#8211; Personalized Cancer Vaccines<\/em><\/strong>&nbsp;<\/p>\n\n\n\n<p>This &#8220;allocated fund&#8221; from a private donator was granted in February 2016 for 2 years. It was awarded to the research group of Prof. Lana Kandalaft (CHUV).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2012 &#8211; December 2017<\/h3>\n\n\n\n<p><strong><em>Immunomodulation of gastrointestinal sarcoma based on NK cell triggering<\/em><\/strong><\/p>\n\n\n\n<p>Collaboration between the CHUV, Lausanne and the IGR, Paris. This \u201callocated fund\u201d from a private donator was granted in January 2012 for 5 years (+ 1 year). Unit INSERM U1015 and Center of Clinical Investigations IGR\/Curie. Director: Prof. Laurence Zitvogel and Alexander Eggermont, IGR &#8211; Institute Gustave Roussy.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2012 &#8211; December 2017<\/h3>\n\n\n\n<p><strong><em>Mechanisms of sarcoma initiation and development<\/em><\/strong><\/p>\n\n\n\n<p>Collaboration between the CHUV, Lausanne and the IGR, Paris. This \u201callocated fund\u201d from a private donator was granted in January 2012 for 5 years (+ 1 year). Research laboratory: Institute of Pathology, UNIL\/CHUV, Lausanne. Director: Prof. Ivan Stamenkovic<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">August 2013 &#8211; July 2017<\/h3>\n\n\n\n<p>ISREC grant &#8220;Molecular biology of cancer and infection&#8221;<\/p>\n\n\n\n<p><strong><em>The role of epithelial-to-mesenchymal transition in non-small cell lung cancer<\/em><\/strong><\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Svenja Groeneveld in August 2013 for 4 years. She worked in the group of Prof. Etienne Meylan (EPFL\/SV\/ISREC).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 3 \u2013 August 25, 2017<\/h3>\n\n\n\n<p>Grants for 5 students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 6 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">March 2011 &#8211; February, 2017<\/h3>\n\n\n\n<p>ISREC chair &#8220;Translational Oncology &#8220;<\/p>\n\n\n\n<p><strong><em>Signaling mechanisms and novel treatment strategies for hematological malignancies<\/em><\/strong><\/p>\n\n\n\n<p>This chair was allocated in March 2011 for a period of six years. It was awarded to the research group of Prof. Oliver Hantschel (EPFL\/SV\/ISREC).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2013 &#8211; August 2016<\/h3>\n\n\n\n<p>ISREC grant &#8220;Molecular life sciences&#8221;<\/p>\n\n\n\n<p><strong><em>Spatiotemporal control of proprotein convertases at cellular and tissue levels&nbsp;<\/em><\/strong>&nbsp;<\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Pierpaolo Ginefra in January 2013 for four years. Pierpaolo Ginefra is working in the group of Prof. Daniel Constam (EPFL\/SV\/ISREC).&nbsp;<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 4 \u2013 August 26, 2016<\/h3>\n\n\n\n<p>Grants for 6 students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 6 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">February 2012 &#8211; January 2016<\/h3>\n\n\n\n<p>Grant \u201cCancer and Immunology&#8221;<\/p>\n\n\n\n<p><em><strong>Crosstalk between T lymphocytes and melanoma cells<\/strong><\/em><\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Natalie Neubert in February 2012 for four years. Natalie Neubert was working in the group of Prof. Daniel Speiser (Clinical Tumor Biology &amp; Immunotherapy Group, LICR@UNIL).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">February 2012 &#8211; January 2016<\/h3>\n\n\n\n<p>Grant \u201cCancer and Immunology&#8221;<\/p>\n\n\n\n<p><em><strong>Endoplasmic reticulum stress in cancer<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated grant\u201d was awarded to Bojan Bujisic by the EMPIRIS charitable umbrella foundation in January 2015 for one year. Bojan Bujisic is working in the group of Prof. Fabio Martinon (Department of Biochemistry, UNIL).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 6 \u2013 August 27, 2015<\/h3>\n\n\n\n<p>Grants for 7 students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 5 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">June 2013 &#8211; May 2015<\/h3>\n\n\n\n<p>Fund \u201cTranslational Research \u2013 Cancer Immunotherapy\u201d<\/p>\n\n\n\n<p><em><strong>Engineering T lymphocytes for long-term cancer therapy<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from a private donator was allocatedin June 2013 for two years. It was awarded to the research group of Dr Nathalie Rufer (LICR@UNIL).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">June 2011 \u2013 May 2015<\/h3>\n\n\n\n<p>Grant \u201cCancer and Immunology\u201d<\/p>\n\n\n\n<p><em><strong>Role of mesenchymal Notch signaling in melanoma development and progression<\/strong><\/em><\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Elena Menietti in June 2011 for four years.<br>Elena Menietti is working in the group of Prof. Gian-Paolo Dotto (Department of Biochemistry, UNIL).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">June 2011 \u2013 May 2015<\/h3>\n\n\n\n<p>Grant \u201cCancer and Immunology\u201d<\/p>\n\n\n\n<p><strong><em>The role of the Notch receptor in CD4 TH17 cell differentiation and its relevance in cancer<\/em><\/strong><\/p>\n\n\n\n<p>This \u201cISREC grant\u201d was awarded to Manuel Coutaz in June 2011 for four years. Manuel Coutaz is working in the group of Prof. Fabienne Tacchini-Cottier (Department of Biochemistry, UNIL).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 3 \u2013 August 27, 2014<\/h3>\n\n\n\n<p>Grants for 7 students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 5 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">June 2011 &#8211; May 2014<\/h3>\n\n\n\n<p>Fund \u201cTranslational Research \u2013 Glioblastoma\u201d<\/p>\n\n\n\n<p><em><strong>Embryonic stem cells for the modelization of brain tumor<\/strong><\/em><\/p>\n\n\n\n<p>This \u201callocated fund\u201d from a private donator was awarded to Dr.&nbsp;Olivier Preynat-Seauve (Laboratory for Immunohematology, University Hospital of Geneva) in June 2011 for three years.&nbsp;<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">October 2008 \u2013 September 2013<\/h3>\n\n\n\n<p>Allocated grant &#8220;Richard and Rita Barm\u00e9&#8221;<\/p>\n\n\n\n<p><em><strong>Function of telomeres and their molecular composition<\/strong><\/em><\/p>\n\n\n\n<p>This grant was awarded for 48 months to Larissa Grolimund, PhD student in the laboratory of Prof. Joachim Lingner, ISREC@EPFL.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 4 \u2013 August 28, 2013<\/h3>\n\n\n\n<p>Grants for 6 students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and 5 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">September 2009 \u2013 August 2013<\/h3>\n\n\n\n<p>ISREC grant &#8220;Molecular biology of cancer and infection&#8221; Identification of Hes1 target genes in murine and human T-ALL This grant was awarded for four years to Sylvia Wirth, PhD student in the laboratories of Prof. Freddy Radtke, ISREC@EPFL.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">June 2011 \u2013 May 2013<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research \u2013 Cancer Immunotherapy&#8221; Tumor targeting of innate and adaptive immune responses via combined CD1d-antitumor therapy and CpG-based cancer vaccine This fund was awarded for two years to the research group of Prof. Pedro Romero, LICR@UNIL.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">April 21 \u2013 26, 2013<\/h3>\n\n\n\n<p>Partnership in the Gordon research conferences &#8220;Stem cells and cancer&#8221;, Les Diablerets, Switzerland.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">2005 \u2013 2013<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research &#8211; Stem cells&#8221; Discovery of new therapeutic targets in the tumor microenvironment This fund was awarded in 2005 to the research groups of Prof. Michel Aguet, ISREC@EPFL and Prof. Ivan Stamenkovic, UNIL\/CHUV.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 9 \u2013 August 31, 2012<\/h3>\n\n\n\n<p>Support of 6 students of the Summer Research Program for undergraduate students &#8211; EPFL School of Life Sciences and of 5 students of the Summer Undergraduate Research Program &#8211; School of Biology University of Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">August 21 \u2013 25, 2012<\/h3>\n\n\n\n<p>Partnership in the Arolla 2012 symposium \u201cCell and developmental systems\u201d, Arolla, Switzerland.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">January 2011 \u2013 March 2012<\/h3>\n\n\n\n<p>Allocated fund &#8220;Translational research &#8211; Metastasis&#8221;<\/p>\n\n\n\n<p><strong><em>Role of the tumor microenvironment in promoting metastasis of breast cancer relapsing after radiotherapy<\/em><\/strong><\/p>\n\n\n\n<p>This fund was allocated for 15 months to Prof. Curzio R\u00fcegg (Chair of Pathology, Department of Medicine, Faculty of Science, University of Fribourg).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">September 7 \u2013 10, 2011<\/h3>\n\n\n\n<p>Partnership in the ISREC symposium 2011 &#8220;Hallmarks and horizons of cancer&#8221; \u2013 School of Life Sciences, EPFL, Lausanne.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 4 \u2013 August 26, 2011<\/h3>\n\n\n\n<p>Support of thirteen students from the &#8220;Summer Research Program \u2013 SRP(EPFL)-SUR(UNIL)&#8221;, 7 students from the EPFL and 6 students from the UNIL for training in cancer research laboratories.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">October 31 \u2013 November 4, 2010<\/h3>\n\n\n\n<p>Partnership in the conference &#8220;Tumor-host interaction and angiogenesis : Mechanisms and therapeutic implication&#8221; Monte Verit\u00e0, Ascona, Switzerland.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 5 \u2013 August 27, 2010<\/h3>\n\n\n\n<p>Support of 12 students from the &#8220;Summer Research Program &#8211; SRP(EPFL)-SUR(UNIL)&#8221;, 6 students from the EPFL in laboratories of the ISREC\/EPFL and 6 students from the UNIL for training in cancer research laboratories.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">March 2009 \u2013 March 2010<\/h3>\n\n\n\n<p>Allocated grant &#8220;Echec au cancer de la Broye&#8221;<\/p>\n\n\n\n<p><em><strong>Quantitative analysis and mathematical modelling of polarity establishment in C. elegans embryos<\/strong><\/em><\/p>\n\n\n\n<p>This grant was awarded for one year to Mr Simon Blanchoud, PhD student in the laboratory of Prof. Pierre G\u00f6nczy, Swiss Institute for Experimental Cancer Research, EPFL.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 6 \u2013 August 28, 2009<\/h3>\n\n\n\n<p>Support of 4 students from the &#8220;Summer Research Program &#8211; EPFL&#8221; in laboratories of the ISREC\/EPFL.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">March 24 \u2013 25, 2009<\/h3>\n\n\n\n<p>Partnership in the 4th scientific meeting of the &#8220;Canc\u00e9rop\u00f4le CLARA&#8221; Archamps, Haute Savoie, France.&nbsp;<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">July 7 \u2013 September 5, 2008<\/h3>\n\n\n\n<p>Support of 6 students from the &#8220;Summer Research Program &#8211; EPFL&#8221; in laboratories of the ISREC\/EPFL.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">August 21 \u2013 23, 2008<\/h3>\n\n\n\n<p>Partnership in the ISREC symposium 2008 &#8220;Cancer and Cell Cycle&#8221; \u2013 School of Life Sciences, EPFL, Lausanne.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Summary of the supported projects List of the funds and grants allocated by the ISREC Foundation since 2008 for the support of translational cancer research projects or for the encouragement of the scientific and academic future in cancer research: July 3, 2023 \u2013 August 25,&nbsp;2023 Grants for 4&nbsp;students of the Summer Research Program for undergraduate [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":2503,"parent":1201,"menu_order":30,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1114","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/pages\/1114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/comments?post=1114"}],"version-history":[{"count":14,"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/pages\/1114\/revisions"}],"predecessor-version":[{"id":4573,"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/pages\/1114\/revisions\/4573"}],"up":[{"embeddable":true,"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/pages\/1201"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/media\/2503"}],"wp:attachment":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/media?parent=1114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}